Evaluation of the effect of oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention: The randomized, double-blind, placebo-controlled, multicenter verapamil slow-release for prevention of cardiovascular events after angioplasty (VESPA) trial

✍ Scribed by Hans-Peter Bestehorn; Franz-Josef Neumann; Heinz Joachim Büttner; Peter Betz; Peter Stürzenhofecker; Eberhard von Hodenberg; Antoine Verdun; Laszlo Levai; Jean Pierre Monassier; Helmut Roskamm

• Book ID: 119264097
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 131 KB
• Volume: 43
• Category: Article
• ISSN: 1558-3597
• DOI: 10.1016/j.jacc.2004.02.047